TrovaGene Announces Licensing of Assay for Hairy Cell Leukemia | IVD Technology

Links shared publicly online about this topic.

15
total visits

TrovaGene Announces Licensing of Assay for Hairy Cell Leukemia | IVD Technology

TrovaGene Inc. has signed a worldwide exclusive license for an assay that detects Hairy Cell Leukemia (HCL). A recent discovery, published in the June 16, 2011, New England Journal of Medicine by Dr. Brunangelo Falini and colleagues, showed that a specific mutation in the BRAF gene was present in all patients with HCL in the study. TrovaGene holds exclusive rights to the discovery and will offer nonexclusive licenses for its diagnostic application.

View full resource at ivdtechnology.com

Tags: Leukemia, Chronic Lymphocytic Leukemia, Hairy Cell Leukemia, Lymphoma, Non-Hodgkin Lymphoma, Genes, Medical, Medicine